SA PRO
Free Account
Kymera Therapeutics, Inc.KYMRNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 92% recommend buying.

Consensus Rating
Buy
25 analysts·High coverage
92%
Rating Distribution
Strong Buy
00%
Buy
2392%
Hold
28%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 27, 2026Barclays
Kymera Therapeutics assumed with an Overweight at Barclays
Target:$133.00
+84.3%from $72.15
Dec 16, 2025RBC Capital
Kymera Therapeutics price target raised to $103 from $70 at RBC Capital
Target:$103.00
+20.3%from $85.62
Dec 11, 2025Stephens
Kymera Therapeutics price target raised to $110 from $65 at Stephens
Target:$110.00
+22.4%from $89.89
Dec 11, 2025Mizuho Securities
Kymera Therapeutics price target raised to $120 from $81 at Mizuho
Target:$120.00
+33.5%from $89.89
Dec 9, 2025Jefferies
Kymera Therapeutics price target raised to $122 from $73 at Jefferies
Target:$122.00
+40.5%from $86.82
Dec 9, 2025Truist Financial
Kymera Therapeutics price target raised to $116 from $80 at Truist
Target:$116.00
+34.5%from $86.27
Dec 9, 2025H.C. Wainwright
Kymera Therapeutics price target raised to $134 from $84 at H.C. Wainwright
Target:$134.00
+54.3%from $86.87
Dec 9, 2025Oppenheimer
Kymera Therapeutics price target raised to $120 from $67 at Oppenheimer
Target:$120.00
+40.2%from $85.59
Dec 9, 2025Morgan Stanley
Kymera Therapeutics price target raised to $127 from $73 at Morgan Stanley
Target:$127.00
+45.6%from $87.21
Dec 9, 2025Piper Sandler
Kymera Therapeutics price target raised to $125 from $98 at Piper Sandler
Target:$125.00
+32.6%from $94.30
Dec 9, 2025Wells Fargo
Kymera Therapeutics price target raised to $116 from $69 at Wells Fargo
Target:$116.00
+23.0%from $94.30
Dec 9, 2025Barclays
Kymera Therapeutics price target raised to $119 from $70 at Barclays
Target:$119.00
+26.2%from $94.30
Dec 8, 2025Leerink Partners
Kymera Therapeutics price target raised to $118 from $70 at Leerink
Target:$118.00
+25.1%from $94.30
Dec 8, 2025BTIG
Kymera Therapeutics price target raised to $138 from $75 at BTIG
Target:$138.00
+46.3%from $94.30
Dec 8, 2025Stifel Nicolaus
Kymera Therapeutics (KYMR) PT Raised to $114 at Stifel
Target:$114.00
+21.6%from $93.76
Nov 26, 2025Truist Financial
Kymera Therapeutics price target raised to $80 from $68 at Truist
Target:$80.00
+18.9%from $67.30
Nov 26, 2025UBS
Kymera Therapeutics price target raised to $90 from $70 at UBS
Target:$90.00
+36.3%from $66.04
Nov 5, 2025H.C. Wainwright
Kymera Therapeutics price target raised to $84 from $70 at H.C. Wainwright
Target:$84.00
+40.2%from $59.91
Nov 5, 2025Barclays
Kymera Therapeutics price target raised to $70 from $60 at Barclays
Target:$70.00
+16.8%from $59.91
Nov 4, 2025Morgan Stanley
Kymera Therapeutics price target raised to $73 from $70 at Morgan Stanley
Target:$73.00
+21.8%from $59.91
Nov 4, 2025Jefferies
Kymera Therapeutics price target raised to $73 from $64 at Jefferies
Target:$73.00
+19.5%from $61.06
Nov 4, 2025Oppenheimer
Kymera Therapeutics (KYMR) PT Raised to $67 at Oppenheimer
Target:$67.00
+11.8%from $59.91
Nov 3, 2025Guggenheim
Guggenheim Assumes Kymera Therapeutics (KYMR) at Buy
Target:$90.00
+45.5%from $61.84
Oct 22, 2025BTIG
Kymera Therapeutics price target raised to $75 from $59 at BTIG
Target:$75.00
+28.6%from $58.32
Oct 1, 2025Oppenheimer
Kymera Therapeutics price target raised to $63 from $53 at Oppenheimer
Target:$63.00
+11.3%from $56.60

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance